Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc. (MRK) Shareholders
Portfolio Pulse from
Levi & Korsinsky law firm has filed a securities class action lawsuit against Merck & Co., Inc. alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion from Gardasil by 2030. On February 4, 2025, Merck announced it would cease Gardasil shipments to China, causing the stock to drop over 9% in a single day.
March 27, 2025 | 11:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck is facing a class action lawsuit alleging securities fraud related to Gardasil sales projections, which could result in financial penalties and investor trust erosion.
The lawsuit directly targets Merck, alleging misleading statements about Gardasil sales in China. The 9% stock drop and potential legal consequences suggest negative short-term impact.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100